Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 250 | $119,261,668 |
Sells | 4 | $198,660,583 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 6,369 | 145.4592 | 926,430 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 537 | 145.4592 | 78,112 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 1,291 | 142.8575 | 184,429 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 109 | 142.8575 | 15,571 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 10,790 | 141.445 | 1,526,192 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 910 | 141.445 | 128,715 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 5,072 | 140.9024 | 714,657 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 427 | 140.9024 | 60,165 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 4,631 | 137.6855 | 637,622 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,693 | 136.9089 | 505,605 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 390 | 137.6855 | 53,697 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 311 | 136.9089 | 42,579 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,144 | 136.1805 | 428,151 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 265 | 136.1805 | 36,088 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 15 Nov 2023 | Purchase | 14,018 | 161.966 | 2,270,439 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 31,530 | 156.4244 | 4,932,061 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 15 Nov 2023 | Purchase | 1,181 | 161.966 | 191,282 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 2,658 | 156.4244 | 415,776 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 61,134 | 0.6928 | 42,354 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 5,041 | 0.6928 | 3,492 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 93,091 | 0.6924 | 64,456 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 7,676 | 0.6924 | 5,315 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 4,434 | 0.6828 | 3,028 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 366 | 0.6828 | 250 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 207,676 | 0.6805 | 141,324 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 17,124 | 0.6805 | 11,653 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 4,342 | 0.665 | 2,887 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 358 | 0.665 | 238 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 1,740,581 | 0.6308 | 1,097,958 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 143,519 | 0.6308 | 90,532 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 26,450 | 6.4215 | 169,849 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 3,118 | 6.4215 | 20,022 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 7,815 | 6.3537 | 49,654 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 921 | 6.3537 | 5,852 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 02 Jun 2022 | Purchase | 2,364 | 5.8202 | 13,759 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 02 Jun 2022 | Purchase | 279 | 5.8202 | 1,624 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 19,789 | 5.7415 | 113,619 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 2,334 | 5.7415 | 13,401 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 1,521 | 5.93 | 9,020 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 179 | 5.93 | 1,061 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 23 May 2022 | Purchase | 7,010 | 5.9874 | 41,972 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 23 May 2022 | Purchase | 827 | 5.9874 | 4,952 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 7,772 | 5.8421 | 45,405 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 946 | 5.8421 | 5,527 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 7,248 | 5.8409 | 42,335 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 883 | 5.8409 | 5,158 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 18 May 2022 | Purchase | 30,003 | 6 | 180,018 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 18 May 2022 | Purchase | 3,654 | 6 | 21,924 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 18 May 2022 | Purchase | 692 | 5.918 | 4,095 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 18 May 2022 | Purchase | 84 | 5.918 | 497 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 17 May 2022 | Purchase | 16,501 | 6.1301 | 101,153 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 17 May 2022 | Purchase | 2,010 | 6.1301 | 12,322 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 16 May 2022 | Purchase | 16,937 | 5.8259 | 98,673 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 16 May 2022 | Purchase | 2,063 | 5.8259 | 12,019 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)